Structures by: Abdul Rahim A. I.
Total: 35
Ethyl 3-nitro-4-(propylamino)benzoate
C12H16N2O4
Acta Crystallographica Section E (2008) 64, 8 o1501-o1502
a=4.4914(4)Å b=12.0828(9)Å c=12.8763(9)Å
α=62.494(4)° β=81.055(4)° γ=83.494(4)°
Ethyl 4-(<i>tert</i>-butylamino)-3-nitrobenzoate
C13H18N2O4
Acta Crystallographica Section E (2008) 64, 8 o1550-o1551
a=16.0471(5)Å b=6.6417(2)Å c=30.0180(9)Å
α=90.00° β=121.688(2)° γ=90.00°
Ethyl 4-fluoro-3-nitrobenzoate
C9H8FNO4
Acta Crystallographica Section E (2009) 65, 3 o556
a=9.9246(3)Å b=13.2883(3)Å c=6.9310(2)Å
α=90.00° β=94.410(2)° γ=90.00°
4-(<i>sec</i>-Butylamino)-3-nitrobenzoic acid
C11H14N2O4
Acta Crystallographica Section E (2009) 65, 7 o1557-o1558
a=6.9722(4)Å b=15.7250(8)Å c=21.8111(11)Å
α=90.00° β=101.896(3)° γ=90.00°
Ethyl 1-<i>tert</i>-butyl-2-(4-hydroxy-3-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O4
Acta Crystallographica Section E (2010) 66, 5 o1051-o1052
a=9.2610(6)Å b=13.6096(9)Å c=16.3200(9)Å
α=90.00° β=113.560(3)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C18H18N2O3
Acta Crystallographica Section E (2010) 66, 7 o1824-o1825
a=8.997(2)Å b=12.988(3)Å c=15.030(3)Å
α=103.764(6)° β=107.202(6)° γ=102.929(6)°
Dimethylammonium 5,5-dimethyl-3-oxo-2-(3,3,6,6-tetramethyl-1,8-dioxo-2,3,4,5,6,7,8,9-\ octahydro-1<i>H</i>-xanthen-9-yl)cyclohex-1-enolate 9-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-3,3,6,6-tetramethyl-\ 3,4,5,6,7,9-hexahydro-1<i>H</i>-xanthene-1,8(2<i>H</i>)-dione <i>n</i>-hexane hemisolvate monohydrate
C2H8N,C25H31O5,C25H32O5,0.5C6H14,H2O
Acta Crystallographica Section E (2010) 66, 2 o470-o471
a=11.2438(2)Å b=20.1671(3)Å c=23.6474(3)Å
α=90.00° β=90.00° γ=90.00°
11-[(<i>E</i>)-Benzylidene]-14-hydroxy-8-phenyl-3,13- diazaheptacyclo[13.7.1.1^9,13^.0^2,9^.0^2,14^.0^3,7^.0^19,23^]tetracosa- 1(22),15,17,19(23),20-pentaen-10-one
C35H30N2O2
Acta Crystallographica Section E (2010) 66, 12 o3045
a=11.2264(19)Å b=15.600(3)Å c=15.031(3)Å
α=90.00° β=93.927(5)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-<i>p</i>-tolyl-1<i>H</i>-benzimidazole-5-carboxylate
C19H20N2O3
Acta Crystallographica Section E (2010) 66, 7 o1590-o1591
a=9.0400(9)Å b=12.6806(13)Å c=15.5504(17)Å
α=74.170(2)° β=74.360(2)° γ=76.721(2)°
4-(butylamino)-3-nitrobenzoic acid
C11H14N2O4
Acta Crystallographica Section E (2009) 65, 5 o1122-o1123
a=14.5188(6)Å b=13.8801(6)Å c=22.5694(9)Å
α=90.00° β=90.233(2)° γ=90.00°
4-Ethylamino-3-nitrobenzoic acid
C9H10N2O4
Acta Crystallographica Section E (2009) 65, 5 o1079
a=3.9354(4)Å b=8.4741(9)Å c=13.8106(15)Å
α=89.256(5)° β=84.730(4)° γ=82.304(4)°
4-<i>tert</i>-butylamino-3-nitrobenzoic acid
C11H14N2O4
Acta Crystallographica Section E (2009) 65, 6 o1233-o1234
a=20.8125(15)Å b=6.7412(5)Å c=8.0793(5)Å
α=90.00° β=90.863(6)° γ=90.00°
4-Cyclobutylamino-3-nitrobenzoic acid
C11H12N2O4
Acta Crystallographica Section E (2009) 65, 7 o1566-o1567
a=9.8555(2)Å b=10.5308(2)Å c=10.9110(2)Å
α=74.8600(10)° β=78.2650(10)° γ=84.8260(10)°
4-(But-3-enylamino)-3-nitrobenzoic acid
C11H12N2O4
Acta Crystallographica Section E (2009) 65, 7 o1560-o1561
a=13.3461(5)Å b=66.777(3)Å c=15.0195(6)Å
α=90.00° β=99.632(2)° γ=90.00°
Ethyl 4-butylamino-3-nitrobenzoate
C13H18N2O4
Acta Crystallographica Section E (2009) 65, 9 o2070-o2071
a=65.292(2)Å b=3.9555(2)Å c=31.4417(11)Å
α=90.00° β=104.833(3)° γ=90.00°
Ethyl 4-(2-hydroxyethylamino)-3-nitrobenzoate
C11H14N2O5
Acta Crystallographica Section E (2010) 66, 4 o846-o847
a=10.6422(6)Å b=14.9954(9)Å c=7.1975(4)Å
α=90.00° β=99.607(2)° γ=90.00°
Ethyl 1-<i>tert</i>-butyl-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2010) 66, 4 o776-o777
a=14.3963(7)Å b=8.6206(5)Å c=15.1609(8)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C20H22N2O2
Acta Crystallographica Section E (2010) 66, 4 o796-o797
a=9.9926(7)Å b=12.3287(11)Å c=13.9635(12)Å
α=90.00° β=93.120(3)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2010) 66, 4 o845
a=10.5815(3)Å b=12.1079(3)Å c=15.1050(3)Å
α=90.00° β=93.678(2)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-<i>p</i>-tolyl-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O2
Acta Crystallographica Section E (2010) 66, 5 o1214-o1215
a=10.6093(7)Å b=12.5617(9)Å c=13.6025(10)Å
α=90.00° β=96.412(2)° γ=90.00°
19-[(<i>E</i>)-4-Chlorobenzylidene]-16-(4-chlorophenyl)-2-hydroxy- 1,11-diazahexacyclo[15.3.1.0^2,10^.0^3,8^.0^10,17^.0^11,15^]henicosa- 3(8),4,6-triene-9,18-dione
C32H26Cl2N2O3
Acta Crystallographica Section E (2010) 66, 6 o1444-o1445
a=14.603(2)Å b=10.5701(14)Å c=21.808(2)Å
α=90.00° β=130.094(6)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(2-hydroxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate 0.25-hydrate
C20H22N2O3,0.25(H2O)
Acta Crystallographica Section E (2010) 66, 6 o1285-o1286
a=7.0484(11)Å b=27.262(4)Å c=9.4673(14)Å
α=90.00° β=97.495(3)° γ=90.00°
9-(4-Hydroxy-3-methoxyphenyl)-3,3,6,6-tetramethyl-3,4,5,6-tetrahydro- 9<i>H</i>-xanthene-1,8(2<i>H</i>,7<i>H</i>)-dione
C24H28O5
Acta Crystallographica Section E (2010) 66, 7 o1538-o1539
a=11.4861(10)Å b=11.8659(11)Å c=30.087(3)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 3-amino-4-[(2-hydroxyethyl)amino]benzoate
C11H16N2O3
Acta Crystallographica Section E (2010) 66, 8 o2141
a=23.2300(5)Å b=14.5914(4)Å c=7.58150(10)Å
α=90.00° β=108.9310(10)° γ=90.00°
2-Hydroxy-16-[(<i>E</i>)-4-methylbenzylidene]-13-(4-methylphenyl)-12-phenyl- 1,11-diazapentacyclo[12.3.1.0^2,10^.0^3,8^.0^10,14^]octadeca-3(8),4,6- triene-9,15-dione
C37H32N2O3
Acta Crystallographica Section E (2010) 66, 8 o2086-o2087
a=42.936(5)Å b=7.3759(9)Å c=17.990(2)Å
α=90.00° β=91.154(2)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-chlorophenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C20H21ClN2O2
Acta Crystallographica Section E (2010) 66, 9 o2412-o2413
a=10.4321(9)Å b=12.6218(12)Å c=13.6896(12)Å
α=90.00° β=97.043(3)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-fluorophenyl)-1<i>H</i>-benzimidazole- 5-carboxylate
C20H21FN2O2
Acta Crystallographica Section E (2011) 67, 11 o2938
a=10.2249(16)Å b=12.3767(18)Å c=14.149(2)Å
α=90.00° β=93.473(2)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole- 5-carboxylate monohydrate
C19H20N2O4,H2O
Acta Crystallographica Section E (2012) 68, 2 o421
a=10.6364(11)Å b=9.5089(10)Å c=19.3765(17)Å
α=90.00° β=112.899(5)° γ=90.00°
Ethyl 2-(4-bromophenyl)-1-<i>sec</i>-butyl-1<i>H</i>-benzimidazole-5-carboxylate
C20H21BrN2O2
Acta Crystallographica Section E (2011) 67, 12 o3453
a=10.5187(2)Å b=12.7525(2)Å c=13.7444(2)Å
α=90.00° β=98.1010(10)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-propyl-1<i>H</i>-benzimidazole-5-carboxylate
C15H20N2O3
Acta Crystallographica Section E (2011) 67, 10 o2704
a=8.5081(3)Å b=8.5573(3)Å c=10.0117(4)Å
α=94.671(3)° β=106.903(2)° γ=98.334(3)°
Ethyl 1-(butan-2-yl)-2-(2-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2011) 67, 12 o3231-o3232
a=10.6746(3)Å b=12.3344(4)Å c=15.6158(5)Å
α=90.00° β=106.9010(10)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-[2-(methylsulfanyl)ethyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C15H20N2O3S
Acta Crystallographica Section E (2012) 68, 1 o197-o198
a=8.39090(10)Å b=8.8277(2)Å c=11.5025(2)Å
α=110.2180(10)° β=102.5290(10)° γ=99.1010(10)°
2-Bromo-4-(3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-yl)-6-methoxyphenol
C18H20BrNO3
Acta Crystallographica Section E (2012) 68, 1 o35-o36
a=7.8056(4)Å b=11.9034(6)Å c=18.9109(9)Å
α=90.00° β=90.00° γ=90.00°
3β-Chloro-6-[2-(2-cyanoacetyl)hydrazin-1-ylidene]-5α-cholestane
C30H48ClN3O
Acta Crystallographica Section E (2012) 68, 4 o1056-o1057
a=11.1623(2)Å b=19.7586(3)Å c=26.4077(4)Å
α=90.00° β=90.00° γ=90.00°
2-<i>sec</i>-Butyl-1-(2-hydroxyethyl)-1<i>H</i>-benzimidazole-5-carboxylic acid
C14H18N2O3
Acta Crystallographica Section E (2012) 68, 7 o1995
a=8.9427(2)Å b=8.2067(2)Å c=18.3536(3)Å
α=90.00° β=94.4150(10)° γ=90.00°